<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01603654</url>
  </required_header>
  <id_info>
    <org_study_id>Low volume preparations</org_study_id>
    <nct_id>NCT01603654</nct_id>
  </id_info>
  <brief_title>Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy</brief_title>
  <official_title>A Randomized Controlled Trial Comparing the Efficacy and Acceptability of Sodium Picosulphate/Magnesium Citrate With Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ASST Fatebenefratelli Sacco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ASST Fatebenefratelli Sacco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate bowel cleansing is essential for effective colonoscopy. Acceptance of colon
      preparation affects the quality of colon cleansing. The study is aimed at comparing the
      efficacy, safety and acceptability of sodium picosulphate/magnesium citrate (PMC) and
      low-volume PEG -ascorbic acid (PEG+ASC)in colon cleansing, and to identify predictors of poor
      bowel preparation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of bowel cleansing</measure>
    <time_frame>Within 24 hrs</time_frame>
    <description>Assessment of quality of colon cleansing at colonoscopy as achieved by the two study products</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>In the 24 hours within assumption of study products</time_frame>
    <description>Occurrence of complications related to the intake or the two study products</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerability</measure>
    <time_frame>Within 12 hrs</time_frame>
    <description>Acceptability of the two study products in term of palatability and ease to take the products</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Colon Cleansing for Colonoscopy</condition>
  <arm_group>
    <arm_group_label>sodium picosulphate/magnesium citrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>low-volume PEG -ascorbic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium picosulphate magnesium citrate</intervention_name>
    <description>Use of the product in colon cleansing before colonoscopy. Two sachets each containing 10 mg of sodium picosulfate, 3.5 g magnesium oxide and 12.0 g citric acid. The 2 doses are taken diluted in a glass water.</description>
    <arm_group_label>sodium picosulphate/magnesium citrate</arm_group_label>
    <other_name>Citrafleet, IBI Lorenzini, Aprilia, Italy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>low-volume PEG -ascorbic acid</intervention_name>
    <description>THe product is used as colon cleanser before colonoscopy. It is supplied as a powder for oral use, to be reconstituted with 2 L of water and drunk as a solution. It consists of 100.0 g macrogol 3350 plus electrolytes (7.5 g sodium sulphate, 2.7 g sodium chloride, 1.0 g potassium chloride) and 4.7 g ascorbic acid.</description>
    <arm_group_label>low-volume PEG -ascorbic acid</arm_group_label>
    <other_name>Moviprep, Norgine Ltd, Harefield, UK</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult outpatients

          -  aged 18-85 years

          -  undergoing elective colonoscopy

        Exclusion Criteria:

          -  previous colon resection

          -  ileus

          -  intestinal obstruction

          -  toxic megacolon

          -  severe heart failure (New York Heart Association [NYHA] Class III or IV)

          -  acute cardiovascular disease

          -  uncontrolled arterial hypertension (systolic pressure &gt; 170 mmHg, diastolic pressure &gt;
             100 mmHg)

          -  severe liver failure or ascites

          -  end-stage renal failure

          -  phenylketonuria

          -  glucose-6-phosphate dehydrogenase deficiency. Women were excluded from the study if
             they were pregnant, breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianpiero Manes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale L. Sacco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale Valduce, Gastroenterologia</name>
      <address>
        <city>Como</city>
        <zip>22100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Paolo</name>
      <address>
        <city>Milano</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale L. Sacco, Endoscopic Unit</name>
      <address>
        <city>Milano</city>
        <zip>20157</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2012</study_first_submitted>
  <study_first_submitted_qc>May 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 22, 2012</study_first_posted>
  <last_update_submitted>May 21, 2012</last_update_submitted>
  <last_update_submitted_qc>May 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ASST Fatebenefratelli Sacco</investigator_affiliation>
    <investigator_full_name>Dr Gianpiero Manes, MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Colon preparation</keyword>
  <keyword>Colonoscopy</keyword>
  <keyword>Polyethylene glycol</keyword>
  <keyword>Sodium Picosulphate</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Magnesium citrate</mesh_term>
    <mesh_term>Picosulfate sodium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

